Literature DB >> 9649916

Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.

C S de Vries1, P B van den Berg, L T de Jong-van den Berg.   

Abstract

In October 1995, a "pill scare" developed in Europe. In the Netherlands, the recommendations given were 1) to not alarm women without risk for deep vein thrombosis (DVT), and 2) to be reserved in prescribing third generation oral contraceptives (OC) for young women who were beginning OC use. To determine whether there is a change in the prescription of third generation OC after the latest pill scare, prescription data from 1/10/94 to 1/10/96, covering a population of +/- 120,000 persons, were studied with respect to OC use before and after the pill scare. Trend analyses revealed a significant decline in third generation compared with total OC prescribing only in the youngest age category (p = 0.0034). Further, switch behavior was studied. Switches from third to second generation OC were more prevalent after the pill scare than before (odds ratio = 2.63; 95% confidence interval 1.84-3.75) and switches from second to third generation OC were significantly less prevalent after the pill scare. This indicates that Dutch prescribers have reacted to the pill scare in the way that the government recommended.

Entities:  

Keywords:  Acceptors--women; Biology; Comparative Studies; Contraception; Contraceptive Methods--side effects; Contraceptive Usage--changes; Developed Countries; Diseases; Embolism; Europe; Family Planning; Family Planning Programs; Netherlands; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Research Methodology; Research Report; Risk Factors; Studies; Thromboembolism; Thrombosis; Vascular Diseases; Western Europe

Mesh:

Substances:

Year:  1998        PMID: 9649916     DOI: 10.1016/s0010-7824(98)00021-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.

Authors:  Lolkje de Jong-van den Berg; Hilde Tobi; Bert Bijker; Paul van den Berg
Journal:  BMJ       Date:  2003-02-01

Review 2.  Impact of safety-related regulatory action on clinical practice: a systematic review.

Authors:  Sigrid Piening; Flora M Haaijer-Ruskamp; Jonie T N de Vries; Menno E van der Elst; Pieter A de Graeff; Sabine M J M Straus; Peter G M Mol
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

Review 3.  Changing prescribing in the light of tolerability concerns: how is this best achieved?

Authors:  C S de Vries; C A Duggan; T F Tromp; L T de Jong-van den Berg
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.228

4.  The French pill scare and the reshaping of social inequalities in access to medical contraceptives.

Authors:  Mireille Le Guen; Mylène Rouzaud-Cornabas; Henri Panjo; Laurent Rigal; Virginie Ringa; Caroline Moreau
Journal:  SSM Popul Health       Date:  2020-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.